BioTelemetry, Inc. (BEAT) was a big mover last session, as the company saw its shares rise by roughly 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 58% in the past one-month time frame.
This medical services company has seen no estimate revision over the past 30 days and its Zacks Consensus Estimate remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
BioTelemetry currently has a Zacks Rank #1 (Strong But) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the same industry include ICON plc (ICLR), Quintiles Transnational Holdings Inc. (Q) and Cancer Genetics, Inc. (CGIX). While ICON and Quintiles Transnational Holdings hold a Zacks Rank #1 (Strong Buy), Cancer Genetics carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
BIOTELEMETRY INC (BEAT): Free Stock Analysis Report
ICON PLC ORD (ICLR): Free Stock Analysis Report
QUINTILES TRANSNATIONAL HOLDINGS (Q): Free Stock Analysis Report
CANCER GENETICS INC (CGIX): Free Stock Analysis Report
Zacks Investment Research